Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Consolidated Net Profit

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-74 Cr₹98 Cr₹142 Cr₹155 Cr₹93 Cr

What is the latest Consolidated Net Profit of INDOCO REMEDIES ?

The latest Consolidated Net Profit ratio of INDOCO REMEDIES is ₹-74 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-74 Cr
Mar2024₹98 Cr
Mar2023₹142 Cr
Mar2022₹155 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of INDOCO REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-74 Cr
Negative
Mar2024 ₹98 Cr
-30.78
Mar2023 ₹142 Cr
-8.11
Mar2022 ₹155 Cr
66.37
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,910.6 Cr -1.6% -9.2% -14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -0.7% -3.6% 6% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr 1.1% -1.2% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr 1.6% 1.4% 36.7% Stock Analytics
CIPLA ₹113,155.0 Cr 0.7% 2.6% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -0.9% -2.5% 1.2% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-1.6%

-9.2%

-14.5%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses